2.375USD+1.71%Mkt Cap: 37.88M USDP/E: —Last update: 2026-06-01
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and inter…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap37.88M USD
Enterprise Value10.05M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-22.73M USD
Revenue/Share—
Last Price2.375 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92536C1036
Valuation
P/E (Trailing)—
P/E (Forward)-2.41
PEG3.60
EV/EBITDA-0.36
EV/Revenue—
P/S—
P/B1.02
EPS (TTM)-0.80
EPS (Forward)-0.98
52W Range
2.0506% of range7.400
52W High7.400 USD
52W Low2.050 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-123.97%
ROA-76.17%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-30.04M USD
CapEx (TTM)1.08K USD
FCF Margin—
FCF Yield-37.72%
Net Debt-27.83M USD
Net Debt/EBITDA0.99
Balance Sheet
Debt/Equity0.17
Current Ratio6.19
Quick Ratio5.69
Book Value/Sh2.313 USD
Cash/Share1.911 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield3.71%
Payout Ratio0.00%
Ex-Div DateApr 28, 2014
Pay DateMay 7, 2014
Splits
Last Split1:10
Split DateAug 11, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)24.50 USD
Target Range24.00 USD – 25.00 USD
# Analysts2
Ownership
Shares Out.16.05M
Float13.48M
Insiders9.78%
Institutions23.92%
Short Interest
Short Ratio10.2d
Short % Float4.09%
Short % Out.3.69%
Shares Short592.67K
Short (prev mo.)656.04K
Technical
SMA 502.295 (+3.5%)
SMA 2002.762 (-14.0%)
Beta-1.17
S&P 52W Chg27.70%
Avg Vol (30d)62.15K
Avg Vol (10d)66.09K
Technical Indicators
RSI (14)55.4
MACD-0.0012
MACD Signal-0.0245
MACD Hist.+0.0233
BB Upper2.392 USD
BB Middle2.233 USD
BB Lower2.074 USD
BB Width14.25%
ATR (14)0.1107 USD
Vol Ratio (20d)0.74x